Cogent Biosciences (COGT) Current Leases (2019 - 2026)
Cogent Biosciences (COGT) posted quarterly Current Leases of $1.4 million for Q1 2026, down 14.15% year-over-year from $1.6 million in Q1 2025, and down 10.6% quarter-over-quarter from $1.5 million in Q4 2025.
Cogent Biosciences (COGT) Current Leases (2019 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Current Leases for 8 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 14.15% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 14.15% YoY), while the FY2025 annual figure was $1.5 million, down 1.15% from the prior year.
- Current Leases fell to $1.4 million in Q1 2026 per COGT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Current Leases topped out at $9.1 million in Q2 2022 and bottomed at $947000.0 in Q1 2023.
- Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases surged 314.7% — and 2023, when it tumbled 87.0%.
- Cogent Biosciences' Current Leases stood at $1.4 million in 2022, then decreased by 2.6% to $1.4 million in 2023, then increased by 12.91% to $1.6 million in 2024, then retreated by 1.15% to $1.5 million in 2025, then declined by 10.6% to $1.4 million in 2026.
- Business Quant data shows COGT's Current Leases at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.61 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 947,000.00 |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 9.06 Mn |
| Mar 31, 2022 | 2.40 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 2.25 Mn |